Entry of hepatitis B and C viruses - Recent progress and future impact

Current Opinion in Virology

Volumn 4, Issue , 2014, Pages 58-65

  Baumert, Thomas F ^a   Meredith, Luke ^b   Ni, Yi ^c   Felmlee, Daniel J ^a   McKeating, Jane A ^b   Urban, Stephan ^c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

ARTICLE; ENDOCYTOSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS TRANSMISSION;

HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; VIRUS INTERNALIZATION;

EID: 84892558871     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.12.002     Document Type: Review

References (67)

1. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 1264 1273
2. D.J. Mutimer, and A. Lok Management of HBV- and HCV-induced end stage liver disease Gut 61 Suppl. 1 2012 i59 i67
3. D. Glebe, and S. Urban Viral and cellular determinants involved in hepadnaviral entry World J Gastroenterol 13 2007 22 38 (Pubitemid 46165460)
4. L.W. Meredith, G.K. Wilson, N.F. Fletcher, and J.A. McKeating Hepatitis C virus entry: beyond receptors Rev Med Virol 22 2012 182 193
5. M.B. Zeisel, D.J. Felmlee, and T.F. Baumert Hepatitis C virus entry Curr Top Microbiol Immunol 369 2013 87 112
6. C. Seeger, and W.S. Mason Hepatitis B virus biology Microbiol Mol Biol Rev 64 2000 51 68 (Pubitemid 30143840)
7. S. Seitz, S. Urban, C. Antoni, and B. Bottcher Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions EMBO J 26 2007 4160 4167 (Pubitemid 47462100)
8. C.M. Bremer, C. Bung, N. Kott, M. Hardt, and D. Glebe Hepatitis B virus infection is dependent on cholesterol in the viral envelope Cell Microbiol 11 2009 249 260
9. V. Bruss Hepatitis B virus morphogenesis World J Gastroenterol 13 2007 65 73 (Pubitemid 46165463)
10. A. Meier, S. Mehrle, T.S. Weiss, W. Mier, and S. Urban The myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding todifferentiated hepatocytes Hepatology 58 2013 31 42
11. M.T. Catanese, K. Uryu, M. Kopp, T.J. Edwards, L. Andrus, W.J. Rice, M. Silvestry, R.J. Kuhn, and C.M. Rice Ultrastructural analysis of hepatitis C virus particles Proc Natl Acad Sci U S A 110 2013 9505 9510
12. A. Merz, G. Long, M.S. Hiet, B. Brugger, P. Chlanda, P. Andre, F. Wieland, J. Krijnse-Locker, and R. Bartenschlager Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome J Biol Chem 286 2011 3018 3032
13. J. Jiang, W. Cun, X. Wu, Q. Shi, H. Tang, and G. Luo Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate J Virol 86 2012 7256 7267
14. H. Barth, C. Schafer, M.I. Adah, F. Zhang, R.J. Linhardt, H. Toyoda, A. Kinoshita-Toyoda, T. Toida, T.H. Van Kuppevelt, E. Depla, W.F. von, H.E. Blum, and T.F. Baumert Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate J Biol Chem 278 2003 41003 41012 (Pubitemid 37280923)
15. G. Abou-Jaoude, and C. Sureau Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange J Virol 81 2007 13057 13066 (Pubitemid 350156944)
16. J. Salisse, and C. Sureau A function essential to viral entry underlies the hepatitis B virus "a" determinant J Virol 83 2009 9321 9328
17. C. Lepere-Douard, M. Trotard, J. LeSeyec, and P. Gripon The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity J Virol 83 2009 11819 11829
18. P. Gripon, J. LeSeyec, S. Rumin, and C. Guguen-Guillouzo Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity Virology 213 1995 292 299
19. V. Bruss, J. Hagelstein, E. Gerhardt, and P.R. Galle Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity Virology 218 1996 396 399 (Pubitemid 26164741)
20. M. Blanchet, and C. Sureau Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues J Virol 81 2007 5841 5849 (Pubitemid 46847021)
21. J. LeSeyec, P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain J Virol 73 1999 2052 2057 (Pubitemid 29098108)
22. Y. Ni, J. Sonnabend, S. Seitz, and S. Urban The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly J Virol 84 2010 3879 3888
23. P. Gripon, S. Rumin, S. Urban, J. LeSeyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo Infection of a human hepatoma cell line by hepatitis B virus Proc Natl Acad Sci U S A 99 2002 15655 15660 (Pubitemid 35403987)
24. P. Gripon, I. Cannie, and S. Urban Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein J Virol 79 2005 1613 1622 (Pubitemid 40459108)
25. J. Petersen, M. Dandri, W. Mier, M. Lutgehetmann, T. Volz, W.F. von, U. Haberkorn, L. Fischer, J.M. Pollok, B. Erbes, S. Seitz, and S. Urban Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein Nat Biotechnol 26 2008 335 341 (Pubitemid 351355128)
26. A. Schulze, A. Schieck, Y. Ni, W. Mier, and S. Urban Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction J Virol 84 2010 1989 2000
27. H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, H. Wang, L. Fu, M. Song, P. Chen, W. Gao, B. Ren, Y. Sun, T. Cai, X. Feng, J. Sui, and W. Li Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus eLife 1 2012 e00049
28. Y. LeDuff, M. Blanchet, and C. Sureau The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent J Virol 83 2009 12443 12451
29. T. Krey, J. d'Alayer, C.M. Kikuti, A. Saulnier, L. Damier-Piolle, I. Petitpas, D.X. Johansson, R.G. Tawar, B. Baron, B. Robert, P. England, M.A. Persson, A. Martin, and F.A. Rey The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule PLoS Pathog 6 2010 e7621000
30. A. Wahid, and J. Dubuisson Virus-neutralizing antibodies to hepatitis C virus J Viral Hepat 20 2013 369 376
31. X. Forns, R. Thimme, S. Govindarajan, S.U. Emerson, R.H. Purcell, F.V. Chisari, and J. Bukh Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees Proc Natl Acad Sci U S A 97 2000 13318 13323
32. T. Krey, A. Meola, Z.Y. Keck, L. Damier-Piolle, S.K. Foung, and F.A. Rey Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape PLoS Pathog 9 2013 e3641003
33. E. Giang, M. Dorner, J.C. Prentoe, M. Dreux, M.J. Evans, J. Bukh, C.M. Rice, A. Ploss, D.R. Burton, and M. Law Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus Proc Natl Acad Sci U S A 109 2012 6205 6210
34. L. Kong, E. Giang, T. Nieusma, J.B. Robbins, M.C. Deller, R.L. Stanfield, I.A. Wilson, and M. Law Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33 J Virol 86 2012 13085 13088
35. J.A. Potter, A.M. Owsianka, N. Jeffery, D.J. Matthews, Z.Y. Keck, P. Lau, S.K. Foung, G.L. Taylor, and A.H. Patel Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody J Virol 86 2012 12923 12932
36. A. Albecka, R. Montserret, T. Krey, A.W. Tarr, E. Diesis, J.K. Ball, V. Descamps, G. Duverlie, F. Rey, F. Penin, and J. Dubuisson Identification of new functional regions in hepatitis C virus envelope glycoprotein E2 J Virol 85 2011 1777 1792
37. D. Lavillette, E.I. Pecheur, P. Donot, J. Fresquet, J. Molle, R. Corbau, M. Dreux, F. Penin, and F.L. Cosset Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus J Virol 81 2007 8752 8765 (Pubitemid 47242848)
38. B. Doring, T. Lutteke, J. Geyer, and E. Petzinger The SLC10 carrier family: transport functions and molecular structure Curr Top Membr 70 2012 105 168
39. G. Zhong, H. Yan, H. Wang, W. He, Z. Jing, Y. Qi, L. Fu, Z. Gao, Y. Huang, G. Xu, X. Feng, J. Sui, and W. Li Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes J Virol 87 2013 7176 7184
40. H. Yan, B. Peng, W. He, G. Zhong, Y. Qi, B. Ren, Z. Gao, Z. Jing, M. Song, G. Xu, J. Sui, and W. Li Molecular determinants restricting mouse sodium taurocholate cotransporting polypeptide for viral entry of hepatitis B and D virus J Virol 87 2013 7977 7991
41. J. Lupberger, M.B. Zeisel, F. Xiao, C. Thumann, I. Fofana, L. Zona, C. Davis, C.J. Mee, M. Turek, S. Gorke, C. Royer, B. Fischer, M.N. Zahid, D. Lavillette, J. Fresquet, F.L. Cosset, S.M. Rothenberg, T. Pietschmann, A.H. Patel, P. Pessaux, M. Doffoel, W. Raffelsberger, O. Poch, J.A. McKeating, L. Brino, and T.F. Baumert EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy Nat Med 17 2011 589 595
42. B. Sainz Jr., N. Barretto, D.N. Martin, N. Hiraga, M. Imamura, S. Hussain, K.A. Marsh, X. Yu, K. Chayama, W.A. Alrefai, and S.L. Uprichard Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor Nat Med 18 2012 281 285
43. D.N. Martin, and S.L. Uprichard Identification of transferrin receptor 1 as a hepatitis C virus entry factor Proc Natl Acad Sci U S A 110 2013 10777 10782
44. C. Davis, H.J. Harris, K. Hu, H.E. Drummer, J.A. McKeating, J.G. Mullins, and P. Balfe In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface Cell Microbiol 14 2012 1892 1903
45. L. Zona, J. Lupberger, N. Sidahmed-Adrar, C. Thumann, H.J. Harris, A. Barnes, J. Florentin, R.G. Tawar, F. Xiao, M. Turek, S.C. Durand, F.H. Duong, M.H. Heim, F.L. Cosset, I. Hirsch, D. Samuel, L. Brino, M.B. Zeisel, N.F. Le, J.A. McKeating, and T.F. Baumert HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex Cell Host Microbe 13 2013 302 313
46. J. Lucifora, K. Esser, and U. Protzer Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes Antivir Res 97 2013 195 197
47. C.L. Brimacombe, J. Grove, L.W. Meredith, K. Hu, A.J. Syder, M.V. Flores, J.M. Timpe, S.E. Krieger, T.F. Baumert, T.L. Tellinghuisen, F. Wong-Staal, P. Balfe, and J.A. McKeating Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission J Virol 85 2011 596 605
48. L.W. Meredith, H.J. Harris, G.K. Wilson, N.F. Fletcher, P. Balfe, and J.A. McKeating Early infection events highlight the limited transmissibility of hepatitis C virus in vitro J Hepatol 58 2013 1074 1080
49. M.T. Catanese, J. Loureiro, C.T. Jones, M. Dorner, H.T. von, and C.M. Rice Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission J Virol 87 2013 8282 8293
50. A.W. Tarr, P. Lafaye, L. Meredith, L. Damier-Piolle, R.A. Urbanowicz, A. Meola, J.L. Jestin, R.J. Brown, J.A. McKeating, F.A. Rey, J.K. Ball, and T. Krey An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission Hepatology 58 2013 932 939
51. T. Volz, L. Allweiss, M.B. M.B.F, M.B. Warlich, M. Lohse, A.W. Pollok, J.M. Alexandrov, A. Urban, S. Petersen, J. Lutgehetmann, and M. Dandri The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus J Hepatol 58 2013 861 867
52. A. Macovei, C. Petrareanu, C. Lazar, P. Florian, and N. Branza-Nichita Regulation of hepatitis B virus infection by Rab5, rAb7, and the endolysosomal compartment J Virol 87 2013 6415 6427
53. C. Stross, A. Helmer, K. Weissenberger, B. Gorg, V. Keitel, D. Haussinger, and R. Kubitz Protein kinase C induces endocytosis of the sodium taurocholate cotransporting polypeptide Am J Physiol Gastrointest Liver Physiol 299 2010 G320 G328
54. C. Stross, S. Kluge, K. Weissenberger, E. Winands, D. Haussinger, and R. Kubitz A dileucine motif is involved in plasma membrane expression and endocytosis of rat sodium taurocholate cotransporting polypeptide (NTCP) Am J Physiol Gastrointest Liver Physiol 305 2013 G722 G730
55. H.C. Huang, C.C. Chen, W.C. Chang, M.H. Tao, and C. Huang Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis J Virol 86 2012 9443 9453
56. L. Meertens, C. Bertaux, and T. Dragic Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles J Virol 80 2006 11571 11578 (Pubitemid 44788871)
57. E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski, and Y. Rouille Hepatitis C virus entry depends on clathrin-mediated endocytosis J Virol 80 2006 6964 6972 (Pubitemid 44025195)
58. M.J. Farquhar, K. Hu, H.J. Harris, C. Davis, C.L. Brimacombe, S.J. Fletcher, T.F. Baumert, J.Z. Rappoport, P. Balfe, and J.A. McKeating Hepatitis C virus induces CD81 and claudin-1 endocytosis J Virol 86 2012 4305 4316
59. M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, and S. Crotta CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes J Virol 82 2008 8316 8329
60. J. Diao, H. Pantua, H. Ngu, L. Komuves, L. Diehl, G. Schaefer, and S.B. Kapadia Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry J Virol 86 2012 10935 10949
61. S. Kim, H. Ishida, D. Yamane, M. Yi, D.C. Swinney, S. Foung, and S.M. Lemon Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry J Virol 87 2013 4214 4224
62. A. Schulze, P. Gripon, and S. Urban Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans Hepatology 46 2007 1759 1768
63. A. Schieck, A. Schulze, C. Gahler, T. Muller, U. Haberkorn, A. Alexandrov, S. Urban, and W. Mier Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts Hepatology 58 2013 43 53
64. C.D. Da, M. Turek, D.J. Felmlee, E. Girardi, S. Pfeffer, G. Long, R. Bartenschlager, M.B. Zeisel, and T.F. Baumert Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells J Virol 86 2012 11919 11925
65. M. Dorner, J.A. Horwitz, J.B. Robbins, W.T. Barry, Q. Feng, K. Mu, C.T. Jones, J.W. Schoggins, M.T. Catanese, D.R. Burton, M. Law, C.M. Rice, and A. Ploss A genetically humanized mouse model for hepatitis C virus infection Nature 474 2011 208 211
66. M.B. Zeisel, I. Fofana, S. Fafi-Kremer, and T.F. Baumert Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies J Hepatol 54 2011 566 576
67. S. Nkongolo et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor J Hepatol 2014 10.1016/j.jhep.2013.11.022